Evidence map›Paper›PMID 25195010›Full record

ArticleNature chemical biology2014

Kinase inhibitors: an allosteric add-on.

Zachariah H Foda, Markus A Seeliger

Abstract readComment
PubMed Publisher
In one paragraph

Article in Nature chemical biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Zachariah H FodaDepartment of Pharmacological Sciences, Stony Brook University School of Medicine, Stony Brook, New York, USA.ORCID 0000000235918482
Markus A SeeligerDepartment of Pharmacological Sciences, Stony Brook University School of Medicine, Stony Brook, New York, USA.

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM008444 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI FROHMAN, MICHAEL A. · 1992 to 2024
$12.6M
Mechanism of allosteric signal integration in Src tyrosine kinaseF30CA174152 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI FODA, ZACHARIAH HUSSEIN · 2013 to 2015
$109k
NCI NIH HHS F30 CA174152NIGMS NIH HHS T32 GM008444
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic AgentsEnzyme InhibitorsHumansIndazolesMAP Kinase Signaling SystemMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3PiperazinesAntineoplastic AgentsEnzyme InhibitorsIndazolesMAPK1 protein, humanMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3PiperazinesSCH772984

Identifiers

PMID25195010

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.